An Open-label Multi-center Trial of Oseltamivir for the Seasonal Prophylaxis of Influenza in Children.
Latest Information Update: 19 Aug 2020
Price :
$35 *
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Roche
- 16 Jul 2008 Actual end date changed from August 2007 to May 2008, according to ClinicalTrials.gov.
- 23 Mar 2008 Actual end date and patient number updated from ClinicalTrials.gov.
- 16 Oct 2007 Status changed from in progress to completed.